CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)
CUSIP: 18914F103
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 416,598,522
- Total 13F shares
- 92,775,680
- Share change
- +10,151,580
- Total reported value
- $292,290,234
- Put/Call ratio
- 44%
- Price per share
- $3.15
- Number of holders
- 173
- Value change
- +$33,084,501
- Number of buys
- 91
- Number of sells
- 51
Quarterly Holders Quick Answers
What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 18914F103:
Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
4.6%
|
19,198,714
|
$54,140,373 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3%
|
12,479,900
|
$35,193,318 | — | 30 Sep 2024 | |
| Chamath Palihapitiya |
3/4/5
|
FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner |
—
class O/S missing
|
30,147,610
|
$29,544,657 | — | 07 Jul 2021 | |
| BlackRock, Inc. |
13F
|
Company |
2.3%
|
9,626,528
|
$27,146,810 | — | 30 Sep 2024 | |
| GREENOAKS CAPITAL PARTNERS LLC |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
25,754,556
|
$24,466,828 | — | 22 Nov 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
4,828,701
|
$13,621,933 | — | 30 Sep 2024 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
1.2%
|
4,810,668
|
$13,566,084 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.72%
|
3,000,505
|
$8,461,424 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.66%
|
2,758,636
|
$7,779,354 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.53%
|
2,189,380
|
$6,174,052 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.45%
|
1,879,198
|
$5,299,338 | — | 30 Sep 2024 | |
| Scott J. Leffler |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
4,857,303
|
$4,760,157 | — | 25 Jan 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.39%
|
1,638,951
|
$4,621,842 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.36%
|
1,514,223
|
$4,270,110 | — | 30 Sep 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.35%
|
1,462,558
|
$4,124,414 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.34%
|
1,408,863
|
$3,972,993 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.34%
|
1,396,640
|
$3,938,525 | — | 30 Sep 2024 | |
| Aric R. Sharp |
3/4/5
|
CEO of Value Based Care |
—
class O/S missing
|
2,100,665
|
$3,907,237 | — | 09 Aug 2024 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.31%
|
1,305,200
|
$3,680,664 | — | 30 Sep 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.27%
|
1,128,171
|
$3,181,442 | — | 30 Sep 2024 | |
| CLOVER HEALTH INVESTMENTS, CORP. /DE |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
3,093,225
|
$3,031,361 | — | 31 Oct 2023 | |
| Joseph R. Martin |
3/4/5
|
General Counsel |
—
class O/S missing
|
2,718,857
|
$2,664,480 | — | 14 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.22%
|
935,912
|
$2,639,271 | — | 30 Sep 2024 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
754,400
|
$2,127,408 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
500,281
|
$1,410,792 | — | 30 Sep 2024 | |
| Nathaniel S. Turner |
3/4/5
|
Director |
—
class O/S missing
|
1,324,728
|
$1,258,492 | — | 07 Jan 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.1%
|
435,576
|
$1,228,324 | — | 30 Sep 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.09%
|
359,392
|
$1,013,000 | — | 30 Sep 2024 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.08%
|
337,378
|
$951,406 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
308,572
|
$870,173 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
305,268
|
$860,855 | — | 30 Sep 2024 | |
| Prabhdeep Singh |
3/4/5
|
Chief Growth Officer |
—
class O/S missing
|
872,821
|
$855,365 | — | 16 Sep 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.07%
|
302,021
|
$851,700 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.07%
|
296,403
|
$835,856 | — | 30 Sep 2024 | |
| CHOREO, LLC |
13F
|
Company |
0.07%
|
286,802
|
$797,310 | — | 30 Sep 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.07%
|
276,830
|
$780,661 | — | 30 Sep 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.07%
|
272,167
|
$767,511 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.06%
|
260,650
|
$735,032 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.06%
|
254,600
|
$717,972 | — | 30 Sep 2024 | |
| Aster Capital Management (DIFC) Ltd |
13F
|
Company |
0.06%
|
240,270
|
$677,561 | — | 30 Sep 2024 | |
| SAGE RHINO CAPITAL LLC |
13F
|
Company |
0.05%
|
211,650
|
$596,853 | — | 30 Sep 2024 | |
| BOURGEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.04%
|
173,710
|
$489,863 | — | 30 Sep 2024 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.04%
|
171,000
|
$482,000 | — | 30 Sep 2024 | |
| Turtle Creek Wealth Advisors, LLC |
13F
|
Company |
0.04%
|
170,000
|
$479,400 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.04%
|
169,300
|
$476,580 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
158,920
|
$448,155 | — | 30 Sep 2024 | |
| SignalPoint Asset Management, LLC |
13F
|
Company |
0.04%
|
150,684
|
$424,929 | — | 30 Sep 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.04%
|
146,460
|
$413,000 | — | 30 Sep 2024 | |
| CREDIT AGRICOLE S A |
13F
|
Individual |
0.04%
|
146,000
|
$411,720 | — | 30 Sep 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.03%
|
145,800
|
$411,156 | — | 30 Sep 2024 |
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q4 2024
As of 31 Dec 2024,
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by
173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,775,680 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, Qube Research & Technologies Ltd, PNC Financial Services Group, Inc., MARSHALL WACE, LLP, STATE STREET CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
174
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
154
Q4 2024 holders
173
Holder diff
19
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.